{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:26:09Z","timestamp":1791462369867,"version":"4.3.4"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["81900805"],"award-info":[{"award-number":["81900805"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["81970698"],"award-info":[{"award-number":["81970698"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014717","name":"National Natural Science Foundation of China National Outstanding Youth Science Fund Project","doi-asserted-by":"publisher","award":["81970708"],"award-info":[{"award-number":["81970708"]}],"id":[{"id":"10.13039\/100014717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.phrs.2022.106278","type":"journal-article","created":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T12:38:32Z","timestamp":1653568712000},"page":"106278","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association between biologic therapy and fracture incidence in patients with selected rheumatic and autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"181","author":[{"given":"Fang","family":"Lv","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suiyuan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2022.106278_bib1","doi-asserted-by":"crossref","unstructured":"Consensus development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med 1993;94:646\u2013650.","DOI":"10.1016\/0002-9343(93)90218-E"},{"key":"10.1016\/j.phrs.2022.106278_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bonr.2017.10.003","article-title":"Is osteoporosis an autoimmune mediated disorder?","volume":"7","author":"Iseme","year":"2017","journal-title":"Bone Rep."},{"key":"10.1016\/j.phrs.2022.106278_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s42358-021-00179-3","article-title":"Osteoporotic fractures in rheumatoid arthritis patients in Argentina: a matched retrospective cohort study","volume":"61","author":"Pierini","year":"2021","journal-title":"Adv. Rheumatol."},{"key":"10.1016\/j.phrs.2022.106278_bib4","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00198-013-2548-6","article-title":"IL-17A-mediated sRANK ligand elevation involved in postmenopausal osteoporosis","volume":"25","author":"Moln\u00e1r","year":"2014","journal-title":"Osteoporos. Int"},{"key":"10.1016\/j.phrs.2022.106278_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00198-016-3769-2","article-title":"Biologic therapies and bone loss in rheumatoid arthritis","volume":"28","author":"Zerbini","year":"2017","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.phrs.2022.106278_bib6","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s00198-018-4491-z","article-title":"Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study","volume":"29","author":"Paskins","year":"2018","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.phrs.2022.106278_bib7","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/annrheumdis-2016-210441","article-title":"The risk of fracture among patients with psoriatic arthritis and psoriasis: a population-based study","volume":"76","author":"Ogdie","year":"2017","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2022.106278_bib8","first-page":"465","article-title":"Prevalence and risk factors of osteoporosis in patients with ankylosing spondylitis: a 5-year follow-up study of 504 cases","volume":"33","author":"Wang","year":"2015","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.phrs.2022.106278_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11657-019-0667-1","article-title":"A meta-analysis of secondary osteoporosis in systemic lupus erythematosus: prevalence and risk factors","volume":"15","author":"Gu","year":"2019","journal-title":"Arch. Osteoporos."},{"key":"10.1016\/j.phrs.2022.106278_bib10","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.maturitas.2013.09.009","article-title":"Inflammatory bowel disease and the risk of osteoporosis and fracture","volume":"76","author":"Targownik","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/j.phrs.2022.106278_bib11","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1136\/annrheumdis-2020-217892","article-title":"Systemic evaluation of the relationship between psoriasis, psoriatic arthritis and osteoporosis: observational and Mendelian randomisation study","volume":"79","author":"Xia","year":"2020","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2022.106278_bib12","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s00198-012-2113-8","article-title":"Osteoporosis drug therapy strategies in the setting of disease-modifying agents for autoimmune disease","volume":"24","author":"Ricciardi","year":"2013","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.phrs.2022.106278_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.semarthrit.2014.05.008","article-title":"Effect of TNF-alpha inhibitor treatment on bone mineral density in patients with ankylosing spondylitis: a systematic review and meta-analysis","volume":"44","author":"Haroon","year":"2014","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106278_bib14","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/rheumatology\/kez655","article-title":"The impact of long-term biologics\/target therapy on bone mineral density in rheumatoid arthritis: a propensity score-matched analysis","volume":"59","author":"Chen","year":"2020","journal-title":"Rheumatology"},{"key":"10.1016\/j.phrs.2022.106278_bib15","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/acr.22519","article-title":"Meta-analysis of tumor necrosis factor inhibitors and glucocorticoids on bone density in rheumatoid arthritis and ankylosing spondylitis trials","volume":"67","author":"Siu","year":"2015","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.phrs.2022.106278_bib16","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.phrs.2022.106278_bib17","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.devcel.2005.02.017","article-title":"Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation","volume":"8","author":"Glass","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.phrs.2022.106278_bib18","doi-asserted-by":"crossref","first-page":"4605","DOI":"10.1074\/jbc.271.9.4605","article-title":"Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells","volume":"271","author":"Jimi","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2022.106278_bib19","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/945945","article-title":"Bone effects of biologic drugs in rheumatoid arthritis","volume":"2013","author":"Corrado","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.phrs.2022.106278_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/art.25053","volume":"62","author":"Garnero","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106278_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.semarthrit.2012.01.004","article-title":"IL-6 receptor inhibition positively modulates bone balance in rheumatoid arthritis patients with an inadequate response to anti-tumor necrosis factor therapy: biochemical marker analysis of bone metabolism in the tocilizumab RADIATE study (NCT00106522)","volume":"42","author":"Karsdal","year":"2012","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106278_bib22","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1365-2036.2004.02097.x","article-title":"Effect of antitumour necrosis factor-alpha therapy on bone turnover in patients with active Crohn\u2019s disease: a prospective study","volume":"20","author":"yan","year":"2004","journal-title":"Aliment Pharm. Ther."},{"key":"10.1016\/j.phrs.2022.106278_bib23","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/MEG.0000000000000719","article-title":"A 1-year prospective study of the effect of infliximab on bone metabolism in inflammatory bowel disease patients","volume":"28","author":"Veerappan","year":"2016","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.phrs.2022.106278_bib24","first-page":"855","article-title":"Prospective assessment of body weight, body composition, and bone density changes in patients with spondyloarthropathy receiving anti-tumor necrosis factor-alpha treatment","volume":"35","author":"Briot","year":"2008","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.phrs.2022.106278_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-019-1938-3","article-title":"Effect of disease-modifying anti-rheumatic drugs on bone structure and strength in psoriatic arthritis patients","volume":"21","author":"Simon","year":"2019","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.phrs.2022.106278_bib26","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/annrheumdis-2019-215328","article-title":"Medications associated with fracture risk in patients with rheumatoid arthritis","volume":"78","author":"Ozen","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.phrs.2022.106278_bib27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1002\/jbmr.1489","article-title":"Effects of disease-modifying antirheumatic drugs on nonvertebral fracture risk in rheumatoid arthritis: a population-based cohort study","volume":"27","author":"Kim","year":"2012","journal-title":"J. Bone Min. Res."},{"key":"10.1016\/j.phrs.2022.106278_bib28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/RHU.0b013e3181a5679d","article-title":"Factors influencing fracture risk, T score, and management of osteoporosis in patients with rheumatoid arthritis in the Consortium of Rheumatology Researchers of North America (CORRONA) registry","volume":"15","author":"Coulson","year":"2009","journal-title":"J. Clin. Rheuma"},{"key":"10.1016\/j.phrs.2022.106278_bib29","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1002\/acr.21937","article-title":"Initiation of tumor necrosis factor \u03b1 antagonists and risk of fractures in patients with selected rheumatic and autoimmune diseases","volume":"65","author":"Kawai","year":"2013","journal-title":"Arthritis Care Res."},{"key":"10.1016\/j.phrs.2022.106278_bib30","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00296-008-0576-x","article-title":"Significance of risk factors for osteoporosis is dependent on gender and menopause in rheumatoid arthritis","volume":"28","author":"Oelzner","year":"2008","journal-title":"Rheuma Int."},{"key":"10.1016\/j.phrs.2022.106278_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.semarthrit.2016.05.005","article-title":"Prevalence and risk factors of low bone mineral density in psoriatic arthritis: A systematic review","volume":"46","author":"Chandran","year":"2016","journal-title":"Semin Arthritis Rheum."},{"key":"10.1016\/j.phrs.2022.106278_bib32","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.autrev.2013.03.015","article-title":"Biologic therapies and systemic bone loss in rheumatoid arthritis","volume":"12","author":"Dimitroulas","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.phrs.2022.106278_bib33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s11926-012-0252-8","article-title":"Inflammatory rheumatic disorders and bone","volume":"14","author":"Bultink","year":"2012","journal-title":"Curr. Rheuma Rep."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661822002237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:33:07Z","timestamp":1760913187000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661822002237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":33,"alternative-id":["S1043661822002237"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106278","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between biologic therapy and fracture incidence in patients with selected rheumatic and autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2022.106278","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106278"}}